News & Insights
Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discovery
Lightcast reaches an exciting milestone with the limited commercial release of its novel Envisia™ platform.
Lightcast has announced the limited commercial release of its Envisia™ benchtop platform — a breakthrough droplet-based, single-cell functional analysis system designed to accelerate antibody discovery and development.